Tag: Johnson Amp Johnson

Nasdaq
US stocks trade mixed after earnings reports

New York: US stocks traded mixed on Tuesday, with Nasdaq reaching record highs, as corporate earnings reports came out overall positive. At midday, the Dow Jones Industrial Average lost 2.13 points, or 0.01 per cent, to 26,212.47. The S&P 500 increased 5.62 points, or 0.20 per cent, to 2,838.59, reports Xinhua. The Nasdaq Composite Index […]

  • Wednesday, 07 July 2021
JJ
J&J to pay 67 patients Rs 25 lakh compensation each

New Delhi: Johnson & Johnson (J&J) on Thursday told the Delhi High Court that it will pay Rs 25 lakh compensation each to 67 identified patients affected by the company’s faulty articular surface replacement (ASR) hip implants. In his order, Justice Vibhu Bakhru directed Johnson & Johnson to pay compensation to identified patients affected by […]

  • Friday, 30 April 2021
Johnson-Johnson
Johnson & Johnson recalls 33K baby powder bottles in US on asbestos worry

Washington: At least 33,000 bottles of Johnson & Johnson (J&J) baby powder have been recalled by the company in the US after health regulators found asbestos traces in a bottle that was purchased online, reports said. Government officials said customers should stop using powder from the affected batch “immediately”, the BBC reported. Health care giant […]

  • Saturday, 24 April 2021
Human trial of Covid 19 vaccine
Johnson & Johnson plans to start human trial of COVID-19 vaccine by Sept

Mumbai: US-based global healthcare company Johnson & Johnson on Monday announced the selection of a lead COVID-19 vaccine candidate, adding that it expects to initiate testing of the vaccine in humans at the latest by September this year. The first batches of a COVID-19 vaccine could be available for emergency use authorisation in early 2021, […]

  • Sunday, 18 April 2021
COVID-19-vaccine
Johnson & Johnson To Begin Human Trial Of Covid Vaccine In July

New York: Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen). The trial for the vaccine, Ad26.COV2-S, recombinant, was initially scheduled to begin in September. “Based on the strength of the preclinical […]

  • Friday, 16 April 2021
vaccine
Johnson & Johnson COVID-19 Vaccine Candidate Protects Monkeys After Single Dose

New York: A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes Covid-19. “This vaccine led to robust protection against SARS-CoV-2 in rhesus macaques and is now being evaluated in humans,” said study researcher Dan H. Barouch from […]

  • Wednesday, 14 April 2021
Covid-Vaccine-Production
BE Signs Pact With Johnson & Johnson For Covid Vaccine Production

Hyderabad: The Biological E. Limited (BE) on Thursday announced that it has entered into an agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the creation and enhancement of manufacturing capacities for drug substance and drug product for the latter’s COVID-19 vaccine candidate. Johnson & Johnson’s COVID-19 vaccine […]

  • Tuesday, 13 April 2021
vaccine
COVID-19: Johnson & Johnson Pauses Vaccine Trial

Washington: US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its Covid-19 vaccine trial after a participant became unwell. “We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant,” Xinhua news agency quoted […]

  • Sunday, 11 April 2021
vaccine
Covid-19 Vaccine: Aspen Inks Manufacturing Deal With Johnson & Johnson

Durban: South African pharmaceutical company Aspen Pharmacare said it has entered into an agreement with ‘Johnson & Johnson’ (J&J) for the technical transfer and proposed commercial manufacturing of their Covid-19 vaccine candidate. The vaccine candidate, Ad26.COV2-S is currently undergoing clinical trials. Aspen Pharmacare on Monday said it will perform formulation, filling and secondary packaging of […]

  • Saturday, 10 April 2021
scrollToTop